Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin W Bergmann

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
Plos One|September 27, 2023
Higher in-hospital mortality in SARS-CoV-2 omicron variant infection compared to influenza infection-Insights from the CORONA Germany studyJannis Dickow, Melanie A Gunawardene, Stephan Willems, et al.
Journal of Clinical Medicine|September 10, 2021
Prognostic Impact of Acute Cardiovascular Events in COVID-19 Hospitalized Patients-Results from the CORONA Germany StudyMelanie A Gunawardene, Nele Gessler, Peter Wohlmuth, et al.
Heart Rhythm|June 5, 2017
Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trialLucas V Boersma, Hueseyin Ince, Stephan Kische, et al.
Circulation. Arrhythmia and Electrophysiology|April 4, 2019
Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and HemorrhageLucas V Boersma, Hueseyin Ince, Stephan Kische, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 31, 2024
Incidence and predictors of 2-year mortality following percutaneous left atrial appendage occlusion in the EWOLUTION trialErrol W Aarnink, Hueseyin Ince, Stephan Kische, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 29, 2020
Initial and long-term antithrombotic therapy after left atrial appendage closure with the WATCHMANJakob Ledwoch, Kolja Sievert, Lucas V A Boersma, et al.
American Heart Journal|April 6, 2010
Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention: design and rationale of the Abciximab Intracoronary versus intravenously Drug Application in ST-Elevation Myocardial Infarction (AIDA STEMI) trialHolger Thiele, Jochen Wöhrle, Petra Neuhaus, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 22, 2023
Left atrial appendage closure in end-stage renal disease and hemodialysis: Data from a German multicenter registryThomas Fink, Christina Paitazoglou, Martin W Bergmann, et al.
Circulation. Heart Failure|September 13, 2013
Response to letter regarding article, “percutaneous left-ventricular support with the impella-2.5-assist device in acute cardiogenic shock results of the Impella-EUROSHOCK registry”Alexander Lauten, Annemarie E Engström, Christian Jung, et al.
Circulation. Heart Failure|December 6, 2012
Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registryAlexander Lauten, Annemarie E Engström, Christian Jung, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Plos One|September 27, 2023
Higher in-hospital mortality in SARS-CoV-2 omicron variant infection compared to influenza infection-Insights from the CORONA Germany studyJannis Dickow, Melanie A Gunawardene, Stephan Willems, et al.
Journal of Clinical Medicine|September 10, 2021
Prognostic Impact of Acute Cardiovascular Events in COVID-19 Hospitalized Patients-Results from the CORONA Germany StudyMelanie A Gunawardene, Nele Gessler, Peter Wohlmuth, et al.
Heart Rhythm|June 5, 2017
Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trialLucas V Boersma, Hueseyin Ince, Stephan Kische, et al.
Circulation. Arrhythmia and Electrophysiology|April 4, 2019
Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and HemorrhageLucas V Boersma, Hueseyin Ince, Stephan Kische, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 31, 2024
Incidence and predictors of 2-year mortality following percutaneous left atrial appendage occlusion in the EWOLUTION trialErrol W Aarnink, Hueseyin Ince, Stephan Kische, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 29, 2020
Initial and long-term antithrombotic therapy after left atrial appendage closure with the WATCHMANJakob Ledwoch, Kolja Sievert, Lucas V A Boersma, et al.
American Heart Journal|April 6, 2010
Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention: design and rationale of the Abciximab Intracoronary versus intravenously Drug Application in ST-Elevation Myocardial Infarction (AIDA STEMI) trialHolger Thiele, Jochen Wöhrle, Petra Neuhaus, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 22, 2023
Left atrial appendage closure in end-stage renal disease and hemodialysis: Data from a German multicenter registryThomas Fink, Christina Paitazoglou, Martin W Bergmann, et al.
Circulation. Heart Failure|September 13, 2013
Response to letter regarding article, “percutaneous left-ventricular support with the impella-2.5-assist device in acute cardiogenic shock results of the Impella-EUROSHOCK registry”Alexander Lauten, Annemarie E Engström, Christian Jung, et al.
Circulation. Heart Failure|December 6, 2012
Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registryAlexander Lauten, Annemarie E Engström, Christian Jung, et al.
Pageof 10